SUN PHARMA SWOT ANALYSISSTRENGHTS Sun Pharma being a successful organization over the years. They had successfully taken overlots of companies for increasing their product-line e.g. Ranbaxy in 2015. They have a strongpresence in India and US. In India they are the leading pharmaceutical company in India andin US they are on 4thnumber in generic medicines. They usually spent in 7-8% in R&D everyyear for innovation, manufacturing and the continuously focus on research efficiency.[Sun].They have expertise in relatively complex generic pharmaceuticals and have low cost ofskilled manpower and proven track record in design of high technology manufacturingdevices.WEAKNESSESStrict pricing regulations always affect the profitability. The United States Food and DrugAdministration issued observations letters to the Halol facility for serious problems with thetesting programmers. [ETm16] At present Indian pharma sector is relatively unorganized.With entry of branded pharma retail chains the industry is expected to get more and moreorganized in the future. At present, there are a few big players such as Surya Pharmaceutical(Viva), Lifetime Healthcare’s (LifeKen), MedPlus who dominate the organised pharmacyretailing.[Rit12] Even tough competition from other major pharma brands means limitedscope for market share. OPPORTUNITIESIndia, a potential preferred global outsourcing hub for pharma products due to low costskilled labour and they have an opportunity increase healthcare awareness in urban and ruralIndia. According to index mundi 2015, 32% is now urban and as day by day pollution isincreasing in metropolitan city. People are more now aware about their health as well for theirfamily. And even in rural area, people are taking care of sanitation and garbage. As people aregetting aware about health they are asking for more quality healthcare and this could be anopportunity for Sun Pharma to penetrate into the market.